IP Library › Granted Patent US 12,257,368
Granted Patent B2
US 12,257,368 · App. 17/252,036 · Granted Mar 25, 2025

Epithelializing microporous biomaterial for use in avascular environments and in corneal implants

Inventors: Gopalan V. Balaji (Kennett Square, PA); Paul J. Fischer (Wilmington, DE); Thomas B. Schmiedel (Middletown, DE); Anuraag Singh (Hockessin, DE)
Assignee: W. L. Gore & Associates, Inc.
A61L27/56A61L27/16A61L27/34A61L27/44A61L2400/18A61L2430/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,257,368
App. No.
17/252,036
Granted
Mar 25, 2025
Kind
B2
Abstract

A microporous biocomposite that is suitable for surgical implantation in an avascular environment is provided. The microporous biocomposite includes (1) a polymer scaffold having a thickness less than about 100 μm and nodal structures that extend to at least one surface of the polymer scaffold and (2) a hydrophilic coating on the polymer scaffold. In some embodiments, the porous scaffold is a microporous biomaterial with nodal structures that extend from a first surface to a second surface of the microporous biomaterial. The hydrophilic coating may be a node and fibril coating. The microporous biocomposite allows for the integration and sustained viability of epithelial cells on the surface thereof as well as tissue integration and the internal colonization of the biomaterial with other cell types, such as keratocytes and fibroblasts. In at least one embodiment, the microporous biocomposite may be incorporated into an artificial corneal implant or in other avascular mesoplants.

Claims (36)

1. A biocompatible biocomposite comprising:

a polymer scaffold having a thickness less than about 100 μm and including nodal structures that extend from at least one surface of said polymer scaffold, wherein the nodal structures are pillars that provide support to the biocompatible biocomposite; and

a hydrophilic coating on the polymer scaffold, the hydrophilic coating and the polymer scaffold defining a microstructure including pores, and

wherein the microstructure sustains viability of epithelial cells on a surface of the biocompatible biocomposite in an avascular environment.

2. The biocomposite of claim 1 , wherein the polymer scaffold is a microporous biomaterial comprising an expanded fluoropolymer membrane, the microstructure having a node and fibril structure wherein the nodes are interconnected by the fibrils and the pores are formed by voids located between the nodes and fibrils, and

wherein the nodal structures extend from a first surface to a second surface of the polymer scaffold.

3. The biocomposite of claim 1 , wherein the polymer scaffold is a microporous biomaterial comprising an expanded non-fluoropolymer membrane, the microstructure having a node and fibril structure where the nodes are interconnected by the fibrils and the pores formed by voids located between the nodes and fibrils, and

wherein the nodal structures extend from a first surface to a second surface of the polymer scaffold.

4. The biocomposite of claim 1 , wherein the pores have a size greater than about 30 μm.

5. The biocomposite of claim 2 , wherein the hydrophilic coating coats the nodes, the fibrils, and the nodal structures.

6. The biocomposite of claim 5 , wherein the microporous biomaterial is an expanded polytetrafluoroethylene (ePTFE) membrane having the node and fibril microstructure.

7. The biocomposite of claim 2 , wherein said polymer scaffold is an ePTFE membrane having the nodal structures thereon,

wherein the nodal structures are islands of ePTFE attached to and raising from a surface of the ePTFE membrane.

8. The biocomposite of claim 7 , wherein the polymer scaffold is a three-layered structure comprising a first ePTFE membrane having a portion of the nodal structures thereon, a second ePTFE membrane having another portion of the nodal structures thereon, and a biocompatible adhesive positioned between the first and second ePTFE membranes,

wherein the nodal structures are formed of ePTFE.

9. The biocomposite of claim 1 , wherein the hydrophilic coating comprises poly(tetrafluoroethylene-co-vinyl alcohol) or polyvinyl alcohol.

10. An artificial cornea comprising:

a central core including a polymeric corneal substitute; and

a microporous biocomposite surrounding the central core, wherein the microporous biocomposite comprises:

a polymer scaffold having a thickness less than about 100 μm and including nodal structures that extend from at least one surface of the polymer scaffold, wherein the nodal structures are pillars that provide support to the biocompatible biocomposite; and

a hydrophilic coating on the polymer scaffold, the hydrophilic coating and the polymer scaffold defining a microstructure including pores, and

wherein the microporous sustains viability of epithelial cells of a surface of the microporous biocomposite in an avascular environment.

11. The artificial cornea of claim 10 , wherein the polymer scaffold is a microporous biomaterial comprising an expanded fluoropolymer membrane, the microstructure having a node and fibril structure wherein the nodes are interconnected by the fibrils and the pores are formed by voids located between the nodes and fibrils, and

wherein the nodal structures extend from a first surface to a second surface of the polymer scaffold.

12. The artificial cornea of claim 10 , wherein the polymer scaffold is a microporous biomaterial comprising an expanded non-fluoropolymer membrane, the microstructure having a node and fibril structure where the nodes are interconnected by the fibrils and the pores are formed by voids located between the nodes and fibrils, and

wherein the nodal structures extend from a first surface to a second surface of the polymer scaffold.

13. The artificial cornea of claim 10 , wherein the microporous biomaterial is an expanded fluoropolymer having a node and fibril microstructure.

14. The artificial cornea of claim 10 , wherein said pores have a size greater than about 30 μm.

15. The artificial cornea of claim 11 , wherein the hydrophilic coating coats the nodes, the fibrils, and the nodal structures.

16. The artificial cornea of claim 15 , wherein the microporous biomaterial is an expanded polytetrafluoroethylene (ePTFE) membrane having the node and fibril microstructure.

17. The artificial cornea of claim 10 , wherein the polymer scaffold is an ePTFE membrane having the nodal structures thereon,

wherein the nodal structures are islands of ePTFE attached to and raising from a surface of the ePTFE membrane.

18. The artificial cornea of claim 10 , wherein the polymer scaffold is a three-layered structure comprising a first ePTFE membrane having a portion of the nodal structures thereon, a second ePTFE membrane having another portion of the nodal structures thereon, and a biocompatible adhesive positioned between the first and second ePTFE membranes,

wherein the nodal structures are formed of ePTFE.

19. The artificial cornea of claim 10 , wherein the hydrophilic coating comprises poly(tetrafluoroethylene-co-vinyl alcohol) or polyvinyl alcohol.

20. The artificial cornea of claim 10 , wherein the central core is formed of a material permitting epithelial cell growth thereon.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2021
From: BALAJI, GOPALAN V.; FISCHER, PAUL J.; SCHMIEDEL, THOMAS B.; SINGH, ANURAAG
To: W. L. GORE & ASSOCIATES, INC.
Reel/Frame 055642/0001 →
Continuity (2)
Provisional Application 62684843 · Jun 14, 2018
Related Publication 20210252194A1 · Aug 19, 2021
References Cited (116)
US 3953566A · Gore · 1976 [cited by applicant]
US 4693715A · Robert · 1987 [cited by applicant]
US 4865601A · Caldwell et al. · 1989 [cited by applicant]
US 5041225A · Norman · 1991 [cited by applicant]
US 5100689A · Goldberg et al. · 1992 [cited by applicant]
US 5108428A · Capecchi et al. · 1992 [cited by applicant]
US 5183545A · Branca et al. · 1993 [cited by applicant]
US 5282851A · Jacob-LaBarre · 1994 [cited by applicant]
US 5300115A · Py · 1994 [cited by applicant]
US 5300116A · Chirila et al. · 1994 [cited by applicant]
US 5321109A · Bosse et al. · 1994 [cited by applicant]
US 5462781A · Zukowski · 1995 [cited by applicant]
US 5476589A · Bacino · 1995 [cited by applicant]
US 5708044A · Branca · 1998 [cited by applicant]
US 5902745A · Butler et al. · 1999 [cited by applicant]
US 6102946A · Nigam · 2000 [cited by applicant]
US 6106552A · Lacombe et al. · 2000 [cited by applicant]
US 6391055B1 · Ikada et al. · 2002 [cited by applicant]
US 6541589B1 · Baillie · 2003 [cited by applicant]
US 6818018B1 · Sawhney · 2004 [cited by applicant]
US 6976997B2 · Noolandi et al. · 2005 [cited by applicant]
US 7049380B1 · Chang et al. · 2006 [cited by applicant]
US 7306729B2 · Strid et al. · 2007 [cited by applicant]
US 7531611B2 · Sabol et al. · 2009 [cited by applicant]
US 7615282B2 · Lutz et al. · 2009 [cited by applicant]
US 7740020B2 · Lutz et al. · 2010 [cited by applicant]
US 7932184B2 · Ishii · 2011 [cited by applicant]
US 8048440B2 · Chang et al. · 2011 [cited by applicant]
US 8637144B2 · Ford · 2014 [cited by applicant]
US 9139669B2 · Xu et al. · 2015 [cited by applicant]
US 9441088B2 · Sbriglia et al. · 2016 [cited by applicant]
US 9849629B2 · Zagl et al. · 2017 [cited by applicant]
US 9926416B2 · Sbriglia · 2018 [cited by applicant]
US 9932429B2 · Sbriglia · 2018 [cited by applicant]
US 20020007217A1 · Jacob et al. · 2002 [cited by applicant]
US 20030225439A1 · Cook et al. · 2003 [cited by applicant]
US 20030232198A1 · Lamberti et al. · 2003 [cited by applicant]
US 20040049268A1 · Noolandi et al. · 2004 [cited by applicant]
US 20040173978A1 · Bowen et al. · 2004 [cited by applicant]
US 20060025852A1 · Armstrong et al. · 2006 [cited by applicant]
US 20060047311A1 · Lutz et al. · 2006 [cited by applicant]
US 20070075013A1 · Duong et al. · 2007 [cited by applicant]
US 20070168025A1 · Darougar et al. · 2007 [cited by applicant]
US 20080150177A1 · Hook et al. · 2008 [cited by applicant]
US 20080255663A1 · Akpek et al. · 2008 [cited by applicant]
US 20090182421A1 · Silvestrini et al. · 2009 [cited by applicant]
US 20110125260A1 · Shen · 2011 [cited by applicant]
US 20110280952A1 · Caramella et al. · 2011 [cited by applicant]
US 20130090612A1 · De Juan et al. · 2013 [cited by applicant]
US 20130184554A1 · Elsheikh et al. · 2013 [cited by applicant]
US 20140121612A1 · Alster et al. · 2014 [cited by applicant]
US 20150216651A1 · Parel et al. · 2015 [cited by applicant]
US 20150223930A1 · Shiuey · 2015 [cited by applicant]
US 20160167291A1 · Zagl et al. · 2016 [cited by applicant]
US 20160367947A1 · Hollenbaugh et al. · 2016 [cited by applicant]
US 20210244528A1 · Balaji et al. · 2021 [cited by applicant]
CN 1939957A · 2007 [cited by applicant]
CN 102283720A · 2011 [cited by applicant]
EP 2136737A2 · 2009 [cited by applicant]
FR 2649605A1 · 1991 [cited by applicant]
JP 46003112B · 1971 [cited by applicant]
JP 2000503870A · 2000 [cited by applicant]
JP 2000325369A · 2000 [cited by applicant]
JP 2002533159A · 2002 [cited by applicant]
JP 2005527330A · 2005 [cited by applicant]
JP 2010523266A · 2010 [cited by applicant]
JP 2013540521A · 2013 [cited by applicant]
JP 2013544558A · 2013 [cited by applicant]
JP 2014050755A · 2014 [cited by applicant]
MX 2013011483A · 2015 [cited by applicant]
SG 188155A1 · 2013 [cited by applicant]
WO 2004028410A1 · 2004 [cited by applicant]
WO 2006009490A1 · 2006 [cited by applicant]
WO 2008127653A2 · 2008 [cited by applicant]
WO 2018036879A1 · 2018 [cited by applicant]
Barber et al., “The acceptance of a vitreous carbon alloplastic material, Proplast, in the rabbit eye,” Invest. Ophthalmol. Vis. Sci., 19:182-191, (1980). [cited by applicant]
Barber, “Keratoprosthesis: past and present,” Int. Ophthalmol. Clin., 28:103-109, (1988). [cited by applicant]
Bhasin et al., “Integrating Keratoprosthesis, Chapter 26 in Keratoprostheses and Artificial Corneas: Fundamentals and Surgical Applications,” Cortina MS and de la Cruz J. (Eds.) Springer Verlag, New York, 2015. [cited by applicant]
Essen et al., “Biocompatibility of a fish scale-derived artificial cornea: Cytotoxicity cellular adhesion and phenotype, and in vivo immunogenicity”, Biomaterials, vol. 81, (2016), pp. 36-45. [cited by applicant]
Gao et al., “Anterior Segment Prosthesis Development: Evaluation of Expanded Polytetrafluoroethylene as a Sciera-Attached Prosthetic Material”, Cornea vol. 15, No. 2, 1996, pp. 210-214. [cited by applicant]
Goho, AM Artificial Cornea Mimics Natural Counterpart, A new material could increase the availability of corneal transplants, May 22, 2008, https://www.technologyreview.com/s/410170/artificial-cornea-mimics-natural-coun… [cited by applicant]
Hicks et al., “Keratoprostheses: Advancing Toward a True Artificial Cornea”, Surv Ophthalmol., vol. 42, No. 2, Sep.-Oct. 1997, pp. 175-189. [cited by applicant]
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2019/037301, mailed on Dec. 24, 2020, 8 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2019/037296, mailed on Oct. 15, 2019, 15 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2019/037301, mailed on Oct. 7, 2019, 13 pages. [cited by applicant]
Jacob-LaBarre, “Caldwell DR: Development of a new type of artificial cornea for treatment of endstage corneal diseases,” in Gebelein CG, Dunn RL (eds): Progress in Biomedical Polymers, New York, Plenum Press, 27-39, (19… [cited by applicant]
Khan et al., “Keratoprosthesis: an update,” Current Opinion in Ophthalmology, 12:282-287 (2001). [cited by applicant]
Kiang et al., “Surface epithelialization of the type I Boston keratoprosthesis front plate: immunohistochemical and high-definition optical coherence tomography characterization”, Graefes Arch Clin Exp Ophthalmol, vol. … [cited by applicant]
KPMG International, Future State 2030: The global megatrends shaping governments, 2014, 80 pages. [cited by applicant]
Krishna et al., “Expanded polytetrafluoroethylene as a substrate for retinal pigment epithelial cell growth and transplantation in age-related macular degeneration”, Br. J. Ophthalmol, vol. 95, 2011, pp. 569-573. [cited by applicant]
Lamberts et al., “A new alloplastic material for ophthalmic surgery,” Ophthalmic Surg., 9:35-42, (1978). [cited by applicant]
Legeais et al., “A new fluorocarbon for keratoorosthesis,” Comea, 11:538-545, (1992). [cited by applicant]
Legeais et al., “A second generation of biointegrable keratoprosthesis. First in viva evaluation (abstract),” Invest Ophthalmol Vis. Sci., 37 (Suppl):1450, (1996). [cited by applicant]
Legeais et al., “Annual Meeting Abstract Issue”, Arvo., vol. 32, No. 4, Mar. 15, 1991, pp. 1-2. [cited by applicant]
Legeais et al., “Expanded fluorocarbon for keratoprosthesis cellular ingrowth and transparency,” Exp. Eye Res., 58:41-52, (1994). [cited by applicant]
Legeais et al., “Expanded polytetrafluoroethylene and transparency (abstract),” Invest Ophthalmol. Vis. Sci., 33 (Suppl):992, (1992). [cited by applicant]
Legeais et al., “Keratoprosthesis with biocolonizable microporous fluorocarbon haptic,” Arch. Ophthalmol., 113:757-763, (1995). [cited by applicant]
Legeais et al., “Keratoprosthesis: a comparative study of three different microporous polymers and first application in human eyes (abstract),” Invest Ophthalmol. Vis. Sci., 32 (Suppl):778, (1991). [cited by applicant]
Legeais et al., “Pouliquen Y Advances in artificial corneas (abstract),” Invest Ophthalmol Vis. Sci., 36 (Suppl):1466, (1995). [cited by applicant]
Legeais et al., “Surgical management of corneal perforation with expanded polytetrafluoroethylene (Gore-Tex),” Ophthalmic Surg., 22:213-217, (1991). [cited by applicant]
Levy, “An artificial cornea is in sight, thanks to biomimetic hydrogels,” D. Stanford Report, Sep. 13, 2006, https://news.stanford.edu/news/2006/september13/cornea-091306.html. [cited by applicant]
Liu et al., “Graphite/poly (vinyl alcohol) hydrogel composite as porous ringy skirt for artificial cornea”, Materials Science and Engineering, C 29, 2009, pp. 261-266. [cited by applicant]
Ma et al., “Corneal epithelialisation on surface-modified hydrogel implants,” J. Mater Sci. Mater Med., 22:663-670, (2011). [cited by applicant]
OECD, “OECD Science, Technology and Innovation Outlook 2016”, 2016, pp. 1-18. [cited by applicant]
Stoiber et al., “Biological Response to a SupraDescemetic Synthetic Cornea in Rabbits,” Arch. Ophthalmol., 122:1850-1855 (2004). [cited by applicant]
Vijayasekaran et al., “Histologic Evaluation During Healing of Hydrogel Core-and-Skirt Keratoprostheses the Rabbit Eye”, Cornea, vol. 16, No. 3, 1997, pp. 352-359. [cited by applicant]
Wang et al., “Preparation an in-vitro characterization of BC/PVA hygrogel composite for its potential use as artificial cornea material,” Materials Science and Engineering C 30:214-218 (2010). [cited by applicant]
White et al., “Proplast” for keratoprosthesis, Ophthalmic Surg., 19:331-333, (1988). [cited by applicant]
Xiang et al., “T-style keratoprosthesis based on surface-modified poly (2-hydroxyethyl methacrylate) hydrogel for cornea repairs”, Materials Science and Engineering, C 50 ,2015, pp. 274-285. [cited by applicant]
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2019/037296, mailed on Dec. 24, 2020, 9 pages. [cited by applicant]
Lee et al., “Chapter 6 : Corneal Suturing Techniques,” Ophthalmic Microsurgical Suturing Techniques, Jan. 2007, pp. 49-59. [cited by applicant]
Roland Berger Strategy Consultants, “Trend Compendium 2030,” Retrieved on Sep. 9, 2023 from URL : https://espas.secure.europarl.europa.eu/orbis/document/trend-compendium-2030, Jan. 1, 2011, pp. 1-145. [cited by applicant]
Goho, A. M., “Artificial Cornea Mimics Natural Counterpart: A new material could increase the availability of corneal transplants”, MIT Technology Review, Retrived on Oct. 30, 2023, URL: https://www.technologyreview.com… [cited by applicant]
Legeais et al., “A second generation of biointegrable keratoprosthesis. First in viva evaluation (abstract),” Investigative Ophthalmology & Visual Science, 37 (Suppl):1450, (1996). [cited by applicant]
Legeais et al., “Expanded polytetrafluoroethylene and transparency (abstract),” Investigative Ophthalmology & Visual Science, 33 (Suppl):992, (1992). [cited by applicant]
Legeais et al., “Keratoprosthesis: a comparative study of three different microporous polymers and first application in human eyes (abstract),” Investigative Ophthalmology & Visual Science, 32 (Suppl):778, (1991). [cited by applicant]